Megaloblastic Anemia — B12 and Folate Deficiency

DNA Synthesis Impairment and Nuclear-Cytoplasmic Asynchrony

• Both B12 and folate are essential cofactors in one-carbon metabolism, functioning as carriers of one-carbon units required for thymidylate synthase (dTMP synthesis) and methionine synthase (methionine regeneration)
• Deficiency of either cofactor impairs conversion of dUMP to dTMP, the immediate precursor of thymidine triphosphate (dTTP) needed for DNA replication
• Result: Impaired DNA synthesis while RNA and protein synthesis continue normally, producing cells with immature (large) nuclei relative to adult (normal-sized) cytoplasm—the hallmark megaloblastic morphology
• Affected cells progress through more mitotic divisions before reaching terminal maturation, producing hypersegmented neutrophils (>5 lobes) and giant metamyelocytes
• Erythroid precursors display nuclear immaturity with coarse chromatin, irregular nuclear membranes, and cytoplasmic maturation with hemoglobinization

Methionine Synthase Dysfunction and the Methylfolate Trap

• B12 (as methylcobalamin) serves as a cofactor for methionine synthase, which converts 5-methyltetrahydrofolate (5-mTHF) to tetrahydrofolate (THF) and homocysteine to methionine
• In B12 deficiency: 5-mTHF accumulates and cannot be converted to active THF forms (required for other one-carbon reactions), trapping folate in an unusable state—the "methylfolate trap" hypothesis
• This explains why B12 deficiency produces megaloblastic changes despite potentially normal serum folate levels and why folate supplementation alone does not resolve the anemia in B12 deficiency
• Folate deficiency directly reduces available THF pools, directly impairing both thymidylate synthase and methionine synthase pathways
• Both deficiencies also impair purine synthesis, contributing to the severity of DNA replication impairment

Neurological Manifestations Specific to B12 Deficiency

• B12 is required for myelin maintenance via methylation reactions catalyzed by methionine synthase; its absence leads to myelin degeneration and neuronal dysfunction
• Affects primarily the posterior columns (vibration/proprioception), spinocerebellar tracts (ataxia), and lateral corticospinal tracts (weakness), producing subacute combined degeneration (SCD) of the spinal cord
• Elevated homocysteine and methylmalonic acid (accumulates when B12-dependent methylmalonyl-CoA mutase cannot function) may contribute to neurological toxicity through oxidative stress and mitochondrial dysfunction
• Neurological disease develops insidiously and may become irreversible if B12 deficiency is not corrected within months, even if hematological abnormalities resolve
• Folate deficiency does NOT cause neurological disease; this distinction is clinically paramount

Cellular Kinetics and Ineffective Erythropoiesis

• Accelerated apoptosis of megaloblastic erythroid precursors due to cellular stress from impaired DNA synthesis produces ineffective erythropoiesis
• Increased intramedullary hemolysis elevates indirect hyperbilirubinemia and LDH despite low peripheral reticulocyte counts (inappropriately low reticulocyte index)
• Neutrophil precursors also show impaired maturation; however, circulating neutrophils, though hypersegmented, remain functionally adequate
• Megakaryocytes may be affected similarly, producing mild thrombocytopenia in some patients

B12 Deficiency Etiologies

• Pernicious anemia (most common cause in developed countries): Autoimmune destruction of gastric parietal cells producing anti-intrinsic factor (IF) and anti-parietal cell antibodies; prevents IF-mediated B12 absorption in terminal ileum; associations include atrophic gastritis, hypothyroidism, and Grave's disease
• Dietary insufficiency: Strict vegetarian/vegan diets lacking animal products (meat, dairy, eggs); B12 is synthesized only by microorganisms, not animals themselves
• Gastrointestinal pathology:
• Gastrectomy (reduced IF production and reduced intrinsic acid environment)
• Ileal disease/resection (Crohn's disease, surgical resection, tropical sprue)
• Small intestinal bacterial overgrowth (SIBO; bacteria consume B12)
• Pancreatic insufficiency (impaired dissociation of B12-R protein complex, allowing IF binding)
• Medications: Metformin, proton pump inhibitors, H2-receptor antagonists (reduce gastric acid necessary for B12 release from food proteins)
• Congenital disorders: Intrinsic factor deficiency (rare), transcobalamin II deficiency (impaired B12 transport)
• Fish tapeworm infection (Diphyllobothrium latum): Competes for B12 absorption

Folate Deficiency Etiologies

• Dietary insufficiency: Most common worldwide cause; inadequate consumption of leafy greens, legumes, fortified grains, liver; folate is heat-labile and destroyed by cooking
• Alcoholism: Reduced intake, impaired absorption, reduced hepatic storage, increased urinary losses
• Malabsorption: Celiac disease, tropical sprue, Crohn's disease, short bowel syndrome
• Medications:
• Methotrexate and other antifolate drugs (inhibit dihydrofolate reductase)
• Trimethoprim, sulfasalazine, phenytoin, phenobarbital
• Increased demand: Pregnancy, lactation, hyperthyroidism, hemolytic anemia, chronic inflammation
• Dialysis: Folate losses in hemodialysate
• Congenital disorders: Rare transcobalamin deficiencies

Hematologic Symptoms

• Fatigue and dyspnea on exertion: Result from severe anemia (Hb often <8 g/dL at presentation); tissue hypoxia due to reduced oxygen-carrying capacity
• Palpitations and chest discomfort: Compensatory tachycardia and increased cardiac output; may precipitate angina in elderly patients with coronary artery disease
• Pallor of mucous membranes and conjunctivae: Reflects reduced circulating hemoglobin
• Jaundice (mild): Due to indirect hyperbilirubinemia from increased intramedullary hemolysis (LDH markedly elevated, haptoglobin low)

Glossitis and Oral Manifestations (Particularly B12 Deficiency)

• Beefy red, smooth, atrophic tongue ("glossitis"): Result of epithelial atrophy due to impaired DNA synthesis in rapidly dividing cells; may cause burning sensation
• Angular cheilitis (cracks at mouth corners) and aphthous ulcers: From mucosal atrophy

Gastrointestinal Symptoms

• Anorexia, nausea, and constipation: Nonspecific effects of severe anemia
• Diarrhea (particularly in B12 deficiency): May result from bacterial overgrowth in setting of achlorhydria (pernicious anemia) or from neurological involvement of intestinal autonomic fibers
• Loss of appetite and weight loss: Severe cases

Neurological Manifestations (B12 Deficiency ONLY)

• Paresthesias: Usually begin distally in lower extremities (hands/feet "glove-and-stocking" distribution); result from demyelination of peripheral nerves and posterior columns
• Ataxia and gait disturbance: From posterior column involvement (loss of proprioception) and spinocerebellar tract degeneration; patient may have sensory ataxia with positive Romberg sign
• Weakness and hyperreflexia progressing to hyporeflexia: Upper motor neuron signs initially (brisk reflexes, spasticity) from corticospinal tract involvement; later lower motor neuron signs if disease progresses
• Cognitive changes: Memory loss, personality change, depression, and in severe cases, subacute combined degeneration dementia; may be reversible if treated early
• Vibratory sense loss and proprioceptive impairment: Hallmark finding on neurological exam; loss of vibratory sense in lower extremities
• Optic neuropathy (rare): Optic atrophy and vision loss
• Lhermitte sign (rare): Electric shock sensation with neck flexion, indicating spinal cord involvement

Folate Deficiency

• Presents exclusively with hematologic symptoms; NO neurological manifestations
• Buccal ulcers and glossitis: May occur but typically milder than in B12 deficiency
• Absence of neurological findings (negative vibratory/proprioceptive testing) helps distinguish from B12 deficiency

Physical Examination Findings

• Pale conjunctivae and nail beds
• Tachycardia (compensatory)
• Systolic flow murmur (from anemia, high-output state)
• Hepatomegaly and splenomegaly (mild, from extramedullary hematopoiesis and hemolysis)
• B12-specific: Diminished vibration and proprioception in lower extremities, positive Romberg sign, hyperreflexia followed by hyporeflexia, weakness

Complete Blood Count (CBC) Findings

• Macrocytic anemia: MCV >100 fL (often 110-140 fL in severe cases); RBC count normal or low (not proportionally low relative to Hb, producing low normal RBC count with very high RDW)
• RDW elevated (>15%): Reflects increased variation in RBC size
• Reticulocyte count inappropriately low relative to degree of anemia (reticulocyte index <2): Reflects ineffective erythropoiesis
• Hypersegmented neutrophils (≥6 lobes, normal ≤5): Hallmark morphologic finding on blood smear; virtually pathognomonic when present
• Neutropenia and thrombocytopenia (mild): May occur in severe cases
• Anisopoikilocytosis: Marked variation in RBC size and shape

Peripheral Blood Smear Morphology

• Macro-ovalocytes: Large, oval-shaped RBCs (vs. round RBCs in other causes of macrocytosis)
• Anisocytosis: Marked variation in cell size
• Poikilocytosis: Abnormal RBC shapes (teardrop cells, schistocytes)
• Polychromasia: Immature RBCs reflecting elevated reticulocytes (though relatively low for degree of anemia)
• Howell-Jolly bodies: Nuclear remnants (suggest impaired splenic function or splenectomy)
• Basophilic stippling: RNA remnants
• Giant metamyelocytes: Large, immature neutrophil precursors (sometimes visible on smear)

Serum B12 and Folate Levels

• Serum B12 <200 pg/mL (normal 200-900 pg/mL): Diagnostic of B12 deficiency
• Normal serum B12 does NOT exclude B12 deficiency (10% of cases have "low-normal" levels); consider methylmalonic acid and homocysteine
• Serum B12 may be falsely elevated in myeloproliferative disorders (elevated B12-binding proteins) or falsely low in folate deficiency (impairs B12 metabolism)
• Serum folate <2.5 ng/mL (normal 2.5-20 ng/mL): Diagnostic of folate deficiency
• Serum folate reflects recent dietary intake and is less specific than RBC folate
• RBC folate <160 ng/mL (normal 160-700 ng/mL): More specific marker of tissue folate stores; may be low in both B12 and folate deficiency

Confirmatory Testing for B12 Deficiency

• Methylmalonic acid (MMA) and homocysteine levels:
• Both elevated in B12 deficiency (B12 is cofactor for methylmalonyl-CoA mutase and methionine synthase)
• Both normal in folate deficiency (folate not involved in MMA metabolism)
• This testing clarifies borderline B12 levels and distinguishes B12 from folate deficiency
• Intrinsic factor (IF) antibodies and parietal cell antibodies: Positive in ~50% of pernicious anemia cases; highly specific for autoimmune B12 deficiency; negative tests do not exclude pernicious anemia
• Schilling test (rarely used now): Oral radiolabeled B12 with 24-hour urine collection; low urinary excretion indicates malabsorption; corrects with IF (pernicious anemia) but not with pancreatic enzymes (pernicious anemia vs. pancreatic insufficiency distinction)
• Gastric intrinsic factor testing: Direct measurement (ELISA methods)

Bone Marrow Biopsy (if diagnosis unclear or complications present)

• Indicated if: Diagnostic uncertainty, cytopenias beyond anemia, suspicion of concurrent hematologic malignancy, or inability to obtain adequate serology
• Hypercellular marrow (increased cellularity, often 60-90%): Result of compensatory erythropoiesis
• Megaloblastic erythropoiesis: Enlarged erythroid precursors with immature (dispersed, "lacy") nuclear chromatin pattern appearing coarser than normoblasts; nuclear-cytoplasmic asynchrony is hallmark
• Nuclei appear immature with fine, dispersed chromatin (appearing "open" or "lacy")
• Cytoplasm is hemoglobinized and mature
• Giant metamyelocytes and band cells: Abnormally large neutrophil precursors with hypersegmented nuclei
• Dyserythropoiesis: Abnormal mitotic figures, nuclear pyknosis, karyorrhexis
• Increased apoptosis and intramedullary hemolysis: Many erythroid cells undergo apoptosis before release
• Iron stain: Often reveals iron overload in macrophages from chronic hemolysis (increased iron stores despite anemia—unusual finding)

Laboratory Markers of Hemolysis and Ineffective Erythropoiesis

• Elevated reticulocyte count RELATIVE to severity of anemia (often 2-5% despite Hb 6-8 g/dL)—but ABSOLUTE reticulocyte count may be low, hence reticulocyte index <2
• Elevated LDH (often >500 U/L): Reflects both hemolysis and increased erythroid precursor turnover
• Elevated indirect hyperbilirubinemia (often 2-3 mg/dL): From intramedullary hemolysis
• Low haptoglobin (<25 mg/dL): Consumed by hemoglobin binding
• Elevated urobilinogen in urine: From hemolysis and increased bilirubin metabolism

Additional Diagnostic Tests

• Serum methylmalonic acid and homocysteine: Elevated in B12 deficiency, normal in folate deficiency (critical distinction)
• **Vitamin B12 absorption tests

Immediate stabilisation

• Transfusion is usually unnecessary: the anemia is chronic and hemodynamically compensated by expanded plasma volume. Reserve packed RBCs for angina, high-output failure, or hemodynamic instability, and give small-volume, slow transfusions (with a loop diuretic if needed) because rapid volume expansion can precipitate pulmonary edema.
• Parenteral B12 without waiting for confirmatory labs if subacute combined degeneration is suspected — neurologic recovery is time-dependent.

First-line therapy

• Cobalamin (cyanocobalamin) 1000 mcg IM: typically daily-to-alternate-day for the first week, weekly for a month, then monthly and lifelong in pernicious anemia, gastrectomy, or ileal resection. This is the schedule endorsed by the British Society for Haematology cobalamin/folate guideline and mirrored in routine US practice; there is no equivalent US society guideline.
• High-dose oral cyanocobalamin (1000–2000 mcg daily): effective even without intrinsic factor because roughly 1% is absorbed by passive diffusion. Acceptable for adherent patients without neurologic disease; parenteral therapy is preferred when neurologic signs are present.
• Folic acid 1–5 mg PO daily for documented folate deficiency; reserve for after B12 status is known.

Definitive and cause-directed management

• Treat the underlying lesion: antibiotics for small-bowel bacterial overgrowth, praziquantel for Diphyllobothrium latum, gluten-free diet in celiac disease, discontinue or supplement around metformin/PPI use.
• Leucovorin (folinic acid), not folic acid, rescues methotrexate toxicity, since dihydrofolate reductase is blocked.
• Prevention: the USPSTF recommends 0.4–0.8 mg folic acid daily for all persons planning or capable of pregnancy; ACOG advises a higher dose after a prior neural-tube-defect pregnancy.

Contraindicated

• Folate monotherapy in unconfirmed B12 deficiency — the classic "masking" error.
• Nitrous oxide anesthesia in known or suspected B12 deficiency; it irreversibly oxidises the cobalt centre.

Emergencies

• Treatment-induced hypokalemia (and occasionally hypophosphatemia): as marrow output resumes, potassium is rapidly consumed into newly formed hematopoietic cells. Signalled by falling serum K in the first days of repletion; can cause ventricular arrhythmia and sudden death. Monitor and replete electrolytes during the reticulocyte surge.
• High-output heart failure or demand ischemia: severe anemia plus compensatory tachycardia in an elderly patient with coronary disease. Signalled by new angina, orthopnea, or a widened pulse pressure with a flow murmur. Over-rapid transfusion is itself a precipitant.
• Rapidly progressive subacute combined degeneration, classically after nitrous oxide exposure or after folate given alone. Signalled by ascending paresthesias, loss of vibration/proprioception, and a positive Romberg sign — treat with parenteral B12 immediately rather than awaiting confirmatory assays.

Disease complications

• Irreversible neurologic deficit: demyelination of posterior columns and lateral corticospinal tracts becomes fixed after months. The hematologic picture normalises fully while gait ataxia and spasticity persist — the reason exam stems stress early recognition.
• Neuropsychiatric decline: memory loss, depression, and dementia; partially reversible only if treated early.
• Pernicious anemia sequelae: chronic atrophic gastritis with achlorhydria drives hypergastrinemia and enterochromaffin-like cell hyperplasia, predisposing to type 1 gastric carcinoid and gastric adenocarcinoma; signalled by dyspepsia, weight loss, or iron deficiency. Coexisting autoimmune disease (Hashimoto thyroiditis, vitiligo, type 1 diabetes) clusters here.
• Neural tube defects from periconceptional folate deficiency — the rationale for USPSTF-recommended supplementation.
• Hyperhomocysteinemia, associated with thrombosis and atherosclerosis; note that vitamin-driven homocysteine lowering has not been shown to reduce cardiovascular events.

Complications of getting the diagnosis wrong

• Unmasked iron deficiency: the MCV falls below normal and anemia persists after repletion because iron becomes rate-limiting for the new erythron.
• Misdiagnosis as myelodysplastic syndrome or acute leukemia on a hypercellular, dysplastic marrow, leading to unnecessary intervention.

• Hypersegmented neutrophils (≥6 lobes) plus macro-ovalocytes are the smear buzzwords; they can appear before the MCV rises and persist after treatment begins.
• The one distinction examiners test: methylmalonic acid is elevated in B12 deficiency and normal in folate deficiency, while homocysteine rises in both. B12 is the cofactor for methylmalonyl-CoA mutase; folate is not.
• Single best next step when a macrocytic anemia has neurologic signs: check B12 (with MMA/homocysteine if borderline) and start parenteral cobalamin — do not give folate first. Folate alone corrects the anemia while subacute combined degeneration progresses.
• Posterior columns + lateral corticospinal tracts + spinocerebellar tracts = subacute combined degeneration: loss of vibration/proprioception, spasticity, and sensory ataxia with a positive Romberg sign. Folate deficiency never does this.
• Nitrous oxide irreversibly oxidises the cobalt of cobalamin — the dentist, chronic "whippet" user, or post-op patient with a normal-ish B12 and acute myelopathy.
• Classic associations: pernicious anemia with anti-intrinsic-factor antibodies (specific, but insensitive), atrophic gastritis, and other autoimmune endocrinopathy; ileal Crohn's or resection; Diphyllobothrium latum; strict vegan diet; metformin and long-term PPI use.
• Common distractors: a normal MCV does not exclude B12 deficiency — concurrent iron deficiency or thalassemia trait can normalise it, so look for the high RDW and hypersegmentation. Also distinguish non-megaloblastic macrocytosis (alcohol, liver disease, hypothyroidism, reticulocytosis, hydroxyurea, zidovudine, MDS), which has round macrocytes and no hypersegmentation.
• Orotic aciduria is the trap for "megaloblastic anemia that does not respond to B12 or folate": orotic acid in urine without hyperammonemia (versus ornithine transcarbamylase deficiency, which has both). Treat with uridine monophosphate.